ARTICLE | Finance
A bigger ‘biome
How uBiome will deploy its $83M series C round to develop therapeutics
September 21, 2018 9:00 PM UTC
With direct-to-consumer products and diagnostics on the market, uBiome Inc. has raised an $83 million series C round to leverage its growing microbiome database and build a therapeutics pipeline.
OS Fund led the round, which also saw participation from existing investors 8VC and Y Combinator, new investor Dentsu Ventures and other undisclosed investors...